semaglutide generic availability India's surge | Opinion Generic Semaglutide Pen 0.25 mg

It is yet to be seen how much longer compounding pharmacies will be allowed to distribute compounded semaglutide, despite the fact that the FDA gave them a deadline

Semaglutide should be discontinued when pregnancy is recognized and at least 2 months before a planned pregnancy due to its long half-life

Understanding these differences helps patients and clinicians select the most appropriate formulation based on treatment goals, lifestyle preferences, and individual medical needs

Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate